HTCR
HeartCore Enterprises, Inc.
There isn't enough reported data to score HTCR yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
HTCR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Strong |
HTCR's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
HTCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 0.4x | $1.34 | — |
| Cheap | 0.5x | $1.65 | +23% |
| Fair | 0.8x | $2.59 | +94% |
| Expensive | 6.7x | $23.16 | +1629% |
Historical ranges are pointers, not guarantees.
HTCR's PE is 0.4x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over HTCR in the historical PE scenario, which offers more potential upside but is not a forecast.
HTCR Forward outlook
There aren't enough analyst estimates for HTCR to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
HTCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.46 | +$3.86 |
| Q1 2026 | $5.71 | +$8.71 |
| Q4 2025 | $4.40 | +$5.80 |
| Q3 2025 | -$10.60 | -341% |
| Q2 2025 | -$0.40 | +$8.00 |
| Q1 2025 | -$3.00 | +$4.40 |
| Q4 2024 | -$1.40 | +$2.80 |
| Q3 2024 | $4.40 | +$7.00 |
HTCR has returned to profit: it earned $3.46 per share over the past year, after losing money the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over HTCR on earnings, with more consistent year-over-year improvement.
HTCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $321.4K | -93% |
| Q1 2026 | $1.2M | -65% |
| Q4 2025 | $1.9M | -44% |
| Q3 2025 | $3M | -83% |
| Q2 2025 | $4.7M | +17% |
| Q1 2025 | $3.6M | -29% |
| Q4 2024 | $3.4M | +3.5% |
| Q3 2024 | $17.9M | +281% |
HTCR's revenue has slid since its 2024 peak: $321,428 last quarter, down 93% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -256% | -259 points |
| Q1 2026 | -124% | -89 points |
| Q4 2025 | -66% | +220 points |
| Q3 2025 | -0.4% | -68 points |
| Q2 2025 | 2.3% | +39 points |
| Q1 2025 | -35% | -21 points |
| Q4 2024 | -286% | -191 points |
| Q3 2024 | 68% | +106 points |
HTCR's operating margin was −256% last quarter, down 259 points from the same quarter a year ago, near the bottom of its range since 2020.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over HTCR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over HTCR on profitability, with a higher operating margin.
HTCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.2M | +$846.2K |
| Q4 2025 | -$136.1K | +$1.1M |
| Q3 2025 | -$306.1K | +$1.7M |
| Q4 2024 | -$1.3M | +$604.4K |
| Q3 2024 | -$2M | -$613.5K |
| Q4 2023 | -$1.9M | -$1.3M |
| Q3 2023 | -$1.4M | +$697.9K |
| Q2 2023 | -$491.5K | -271% |
NVDA has the stronger cash trend. Its trailing FCF is up 290% versus its history, compared with HTCR at up 21%.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
HTCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +139K shares |
| 1 year | +4.2% | +56.4K shares |
| 3 years | +35% | +368K shares |
| 5 years | +46% | +442K shares |
HTCR has 1M diluted shares, up 4.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | $2.2M |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over HTCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
HTCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | 10.1x | High |
| Q4 2024 | -0.6x | Net Cash |
| Q3 2024 | 0.1x | Very low |
| Q4 2021 | 18.6x | High |
| Q3 2021 | 7.6x | High |
HTCR has more cash than debt.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HTCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 15.0 | Oversold |
HTCR's weekly RSI is 28 (oversold) and its Stochastic is 15 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
HTCR PE vs Technology Sector
| Metric | HTCR | Sector median | Relative |
|---|---|---|---|
| PE | 0.4x | 28x | 99% below |
| PE % | 2 | 49 | 47 pts below |
HTCR has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
HTCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.65 | 19% below |
| 20 week MA | $2.14 | 37% below |
| 50 week MA | $3.70 | 64% below |
| 100 week MA | $10.6 | 87% below |
| 200 week MA | $14.9 | 91% below |
HTCR is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over HTCR on trend strength, trading above more of its moving averages.
HTCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $82.6 | $16.4 | -80% |
| 2023 | $16.4 | $12.8 | -22% |
| 2024 | $12.8 | $31.0 | +143% |
| 2025 | $31.0 | $6.92 | -78% |
| 2026 YTD | $6.92 | $1.34 | -81% |
HTCR's yearly returns have swung widely, from +143% in 2024 to −80% in 2022. It's down 81% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over HTCR on returns for 2026, with the stronger performance.